SAN FRANCISCO — The drug maker GlaxoSmithKline announced Thursday that it would team up with some of the nation’s most prominent CRISPR researchers to use the gene-editing technology in a search for new medicines, establishing a new lab in San Francisco and spending up to $67 million over five years.
Jennifer Doudna, the University of California, Berkeley, researcher who co-invented the CRISPR enzyme technology, will help lead the effort, along with Jonathan Weissman, a UC San Francisco researcher who has been using CRISPR to understand the function of individual human genes and how they work together. Both are Howard Hughes Medical Institute investigators.
The lab will be called the Laboratory for Genomic Research and will be based near UCSF’s Mission Bay campus. The money will fund 24 full-time University of California employees, in addition to as many as 14 full-time GSK employees. GSK’s machine learning and artificial intelligence groups will create computer systems that can handle the large amounts of data the project is expected to create. It will focus on immunology, oncology, and neurology.
About the Author Reprints
This is the same GSK .that bribed doctors in the United States of America and China . so as to promote the drugs that they produce for the sake of money only . .In the U. S.A . the crime is civil so they pay money billions of dollars to Washington for which they are able to pay easily . no one goes to prison . .in China the offence is criminal even though unfortunately in one case about three [3] years ago they were convicted yet they only paid about five million Pounds .Sterling as G.SK. is a British Conglomorate pharmaceutical empire .